Your browser doesn't support javascript.
loading
The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort study.
Guven, Deniz Can; Yekeduz, Emre; Erul, Enes; Yazgan, Sati Coskun; Sahin, Taha Koray; Karatas, Gokturk; Aksoy, Sercan; Erman, Mustafa; Yalcin, Suayib; Urun, Yuksel; Kilickap, Saadettin.
Afiliação
  • Guven DC; Department of Medical Oncology, Hacettepe University Cancer Institute, Sihhiye, 06100, Ankara, Turkey. denizcguven@hotmail.com.
  • Yekeduz E; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Erul E; Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Yazgan SC; Department of Internal Medicine, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Sahin TK; Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Karatas G; Department of Internal Medicine, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Aksoy S; Department of Medical Oncology, Hacettepe University Cancer Institute, Sihhiye, 06100, Ankara, Turkey.
  • Erman M; Department of Medical Oncology, Hacettepe University Cancer Institute, Sihhiye, 06100, Ankara, Turkey.
  • Yalcin S; Department of Medical Oncology, Hacettepe University Cancer Institute, Sihhiye, 06100, Ankara, Turkey.
  • Urun Y; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Kilickap S; Faculty of Medicine, Istinye University, Istanbul, Turkey.
J Cancer Res Clin Oncol ; 149(7): 3599-3606, 2023 Jul.
Article em En | MEDLINE | ID: mdl-35960374

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article